![Eric Schettini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Schettini
Chief Executive Officer at
TAFALGIE THERAPEUTICS
Profile
Eric Schettini is the founder of Tafalgie Therapeutics SA, founded in 2020, holding the title of President-Executive Board & CEO.
Mr. Schettini currently holds the position of Chairman at Tiempo SAS and serves on the Board of ACG Management SAS.
Eric Schettini active positions
| Companies | Position | Start |
|---|---|---|
Tiempo SAS
 Tiempo SAS SemiconductorsElectronic Technology Designs and develops microelectronic security IP blocks & secure embedded software for securing connected objects | Chairman | - |
TAFALGIE THERAPEUTICS
 TAFALGIE THERAPEUTICS Miscellaneous Commercial ServicesCommercial Services Operates as a CNRS and AMU spin-off company engaged in biopharmaceutical research | Chief Executive Officer | 2019-12-31 |
ACG Management SAS
 ACG Management SAS Investment ManagersFinance ACG Management invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing in the form of equity and quasi-equity for growth and buyout transactions with an average investment size of EUR 4.5 million and also acquires minority stakes in the companies. | Private Equity Investor | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
ACG Management SAS
ACG Management SAS Investment ManagersFinance ACG Management invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing in the form of equity and quasi-equity for growth and buyout transactions with an average investment size of EUR 4.5 million and also acquires minority stakes in the companies. | Finance |
Tiempo SAS
Tiempo SAS SemiconductorsElectronic Technology Designs and develops microelectronic security IP blocks & secure embedded software for securing connected objects | Electronic Technology |
TAFALGIE THERAPEUTICS
TAFALGIE THERAPEUTICS Miscellaneous Commercial ServicesCommercial Services Operates as a CNRS and AMU spin-off company engaged in biopharmaceutical research | Commercial Services |
- Stock Market
- Insiders
- Eric Schettini
